Answers are grounded in this paper and cite their sources.
Highlights the serious risks, particularly ketoacidosis, associated with continuous subcutaneous insulin infusion in diabetic patients.
EDITOR—The editorial by Pickup and Keen about continuous subcutaneous insulin infusion is worrying in advocating this treatment, albeit for a comparatively small proportion of the diabetic population in Britain.1 Pickup and Keen do not highlight adequately the serious risks associated with it for doctors considering introducing this treatment to their patients. Pickup and Keen acknowledge high rates of ketoacidosis with subcutaneous insulin infusion but attribute it to lack of experience, unsuitable pump insulin, and the less reliable devices previously available. They …
No takes yet. Share an insight, caveat, or question.
Graham Knight (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: